MINI FUTURE SHORT - BECTON DICKINSON AND CO. Stock

Certificat

DE000ME7S461

Real-time Bid/Ask 03:14:59 2024-06-18 am EDT
3.2 EUR / 3.42 EUR -0.60% Intraday chart for MINI FUTURE SHORT - BECTON DICKINSON AND CO.
Current month-4.31%
1 month+10.26%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-17 3.33 +3.74%
24-06-14 3.21 -4.46%
24-06-13 3.36 +9.09%
24-06-12 3.08 +0.65%
24-06-11 3.06 +15.04%

Delayed Quote Börse Stuttgart

Last update June 17, 2024 at 03:46 pm EDT

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellPUT
Underlying BECTON, DICKINSON AND COMPANY
Issuer Morgan Stanley
WKN ME7S46
ISINDE000ME7S461
Date issued 2024-01-29
Strike 267.8 $
Maturity Unlimited
Parity 10 : 1
Emission price 2.97
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 4.02
Lowest since issue 1.93
Spread 0.22
Spread %6.43%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
232.8 USD
Average target price
279.2 USD
Spread / Average Target
+19.95%
Consensus